1 year ago
Cabinet Approves Phase III of Biomedical Research Program
India is investing in medical research.
The government has approved Phase III of the Biomedical Research Career Programme.
This program provides funds and support for scientists and researchers.
It includes fellowships and grants to improve healthcare by funding training and encouraging scientists.
It will support collaborative research, mentorship, and networking.
The goal is to make India a leader in biomedical science, train over 2,000 researchers, and increase research support for women.
The Union Cabinet approved Phase III of the Biomedical Research Career Programme.
The program has a total outlay of Rs 3,000 crore.
The program will run from 2025-26 to 2030-31.
The program is a partnership between the DBT, Wellcome Trust (UK), and India Alliance.
The program aims to nurture scientific talent and strengthen research capacity.
- Who
- Union Cabinet, DBT, Wellcome Trust (UK), and India Alliance
- What
- Approved Phase III of the Biomedical Research Career Programme (BRCP)
- Where
- India
- When
- Wednesday
- Why
- To foster innovation, nurture scientific talent, and strengthen research capacity
Key facts
- Program Name
- Biomedical Research Career Programme (BRCP)
- Phase
- III
- Total Outlay
- Rs 3,000 crore
- Implementing Partners
- Department of Biotechnology (DBT), Wellcome Trust (WT), UK, and SPV, India Alliance
- Launched
- 2008-2009 (Phase I)
- Duration
- 2025-26 to 2030-31
Quotes
A Cabinet Communique
A formal statement released by the Cabinet.
“Phases I and II positioned India as an emerging hub for biomedical science of international standing. India’s rising investment in science and its growing role in the global knowledge economy demand a new phase of strategic effort. Building on the gains of earlier Phases, Phase-III will invest in talent, capacity, and translation aligned with national priorities and global benchmarks”
thehansindia.com
“Expected outcomes include training over 2,000 students and postdoctoral fellows, generating high-impact publications, enabling patentable discoveries, earning peer recognition, enabling a 10-15 per cent increase in support to women, 25-30 per cent of collaborative programmes to approach TRL4 and above, and an expanded footprint of activities and engagement in Tier-2/3 settings”
thehansindia.com
